Developer docs
API playgroundTry for free, no card

Search company profiles

doseology

Full company profile

uuid0008e2q

Namestring
doseology
Legal namestring
Doseology Sciences Inc.
Websiteurl
doseology.com
Company typeenum
Public
Founded yearint
2021
Descriptiontext

Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) is a publicly traded Canadian consumer products company headquartered in Kelowna, British Columbia, that develops and commercializes functional wellness and oral stimulant products. Its legacy product line is a portfolio of Health Canada NPN-approved medicinal mushroom tinctures and a cognitive complex powder (branded Wake, Elevate, Boost, Sleep, and Think), sold through Canadian grocery and health food retail including Loblaw, Sobeys/Safeway, Whole Foods Market Canada, and Healthy Planet, and distributed nationally by Connect Brand Management and Peak Performance Products, the latter covering over 3,500 retail doors.

The company's current strategic focus is the oral stimulant pouch category, anchored by the Feed That Brain brand acquired from Joseph Mimran & Associates Inc. in August 2025 for CAD 400,000. The core technology is a buccal/oral stimulant pouch delivery platform designed to deliver controlled doses of caffeine, nootropics, and other functional actives without smoke, vapor, sugar, or liquid. Feed That Brain Energy Pouches launched in the U.S. in March 2026 through a direct-to-consumer pilot at feedthatbrain.com and Amazon.com; a Florida-based wholly owned subsidiary, Doseology USA Inc., was established in March 2025 to support U.S. and, over time, European commercialization. The company has engaged McKinney Regulatory Science Advisors to pursue an FDA PMTA pathway for the platform.

The business model is conventional CPG wholesale plus direct-to-consumer e-commerce. Revenue is generated through one-time unit sales to retail channel partners and end consumers, with pricing not publicly disclosed. The go-to-market is multi-channel: enterprise retail partnerships in Canada, national broker/distributor relationships, an affiliate program targeting influencers and digital nomads, trade show presence at CHFA events, and DTC e-commerce. The company has 1-10 employees, is debt-free, and has funded commercialization through a series of non-brokered private placements totaling approximately CAD 6.2M in 2025-2026, with ownership including Maynard Communication Limited (~10.4%) and Jesse McRae (~13.6%) as of June 2025.

Short descriptiontext

Doseology Sciences Inc. is a publicly traded Canadian consumer health company that sells Health Canada-approved functional mushroom supplements through Canadian grocery and health food retail, and caffeine-based oral stimulant pouches under the Feed That Brain brand via a U.S. DTC pilot, targeting health-conscious consumers seeking portable energy and cognitive performance alternatives.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKelowna, Canada
HQ citystring
Kelowna
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oral stimulant pouches, functional mushroom supplements, caffeine energy pouches, smoke-free nicotine alternatives, nootropic delivery systems
Industry3 codes
PRIMARYCRADAGAI
Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
SECONDARYCRADAGAD
Herbal & Botanical Supplements
SECONDARYCRADAJAI
Nicotine Pouches (Tobacco-Free) Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Food (Health) Supplement Retailers456191
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Consumer Health & Wellness Supplements
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Functional Mushroom Product Sales
TypeOne Time License
Description

Sale of functional mushroom tinctures (Wake, Elevate, Boost, Sleep, Think) through retail and direct-to-consumer channels in Canada. Products are Health Canada NPN-approved medicinal mushroom supplements.

doseology.com
2Oral Stimulant Pouch Sales
TypeOne Time License
Description

Sale of Feed That Brain Energy Pouches through DTC (feedthatbrain.com, Amazon.com) and eventual retail channels. The nicotine-free, caffeine-based oral stimulant pouches represent the company's next-generation product line.

prnewswire.com
3Wholesale/Distribution Revenue
TypeOne Time License
Description

Wholesale product sales through national retail chains including Loblaw, Sobeys, Whole Foods, and other health food retailers across Canada.

doseology.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Marketing or Sales, Technology or R&D, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Feed That Brain
Description

Oral stimulant pouch brand featuring nicotine-free, caffeine-based energy pouches. Launched in U.S. market through direct-to-consumer pilot in March 2026.

doseology.com
Core offering1 text field

Doseology Sciences Inc. develops, manufactures, and sells consumer health products focused on oral stimulant pouches and functional mushroom supplements. Its core offerings include the Feed That Brain line of nicotine-free, caffeine-based oral stimulant pouches sold through DTC and retail channels, and Health Canada NPN-approved medicinal mushroom tinctures (Wake, Elevate, Boost, Sleep) plus the Think cognitive complex powder sold through major Canadian grocery and health-food retailers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Year-over-year sales increased by 224%
+2 more records
Product overview1 text field

Doseology Sciences Inc. operates as a consumer product innovation company specializing in oral stimulant and functional wellness products. The company offers two distinct product lines: (1) Feed That Brain Energy Pouches - nicotine-free, caffeine-based oral stimulant pouches for clean, controlled energy delivery; and (2) Functional Mushroom Supplements - Health Canada NPN-approved tinctures (Wake, Elevate, Boost, Sleep) and Think powder featuring 100% mushroom fruiting bodies for cognitive health, mood support, immunity, and sleep. The Feed That Brain brand was acquired in August 2025 and serves as the company's entry into the oral stimulant pouch market, while the mushroom line represents the original product portfolio sold through Canadian retail channels including Loblaw, Sobeys, Whole Foods, and Amazon.

Product and service3 records
1Feed That Brain Energy Pouches
CategoryOral Stimulant Pouches
Description

Nicotine-free, caffeine-based oral stimulant pouches designed to provide clean, controlled energy in a discreet, portable, and portion-controlled format without sugar, smoke, or liquid consumption. Targeted at health-conscious adult consumers, professionals, and athletes seeking an alternative to traditional energy drinks and tobacco.

2Doseology Functional Mushroom Tinctures (Wake, Elevate, Boost, Sleep)
CategoryFunctional Mushroom Supplements
Description

Health Canada NPN-approved medicinal mushroom tinctures containing 100% mushroom fruiting bodies. Wake promotes wakefulness and cognitive performance; Elevate enhances mood and cognitive clarity; Boost supports immunity; Sleep promotes relaxation and sleep onset. Sold through Canadian grocery, health-food retailers, and e-commerce channels.

3Think Cognitive Complex Powder
CategoryFunctional Mushroom Supplements
Description

Super-shroom cognitive complex powder blending lion's mane, reishi, shiitake, and chaga mushrooms with yerba mate, rhodiola, choline, organic cocoa powder, and monk fruit extract. Formulated to optimize cognitive function and improve focus and alertness.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Strategic partnership with McKinney Regulatory Science Advisors, an FDA regulatory consulting firm, to advance Doseology's regulatory submission strategy for oral pouch technology products. McKinney provides guidance on formulation strategy, PMTA preparation, and post-market compliance to position Doseology for FDA approval and commercial readiness in regulated markets.

Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2025-12-01
Description

Investor Communications Initiative involving collaborations with Guerilla Capital and Maynard Communications Ltd. to improve disclosure practices and investor engagement, supporting long-term strategy for developing oral stimulant platform.

3Joseph Mimran & Associates Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-19
Description

Acquisition of the Feed That Brain division operated by Joseph Mimran & Associates Inc. for $400,000. Joseph Mimran appointed as strategic advisor under a three-year advisory agreement. The transaction includes all business plan, inventory, contracts, material agreements, intangible property, know-how, and goodwill of the Feed That Brain brand.

doseology.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

National CPG firm specializing in sales and marketing for leading natural food and nutraceutical brands, engaged to accelerate revenue and product rollout in Canada through extensive relationships throughout the natural product category in grocery, retail, and pharmacy channels.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Leading distributor of innovative and effective products that optimize health and wellness with a national sales team soliciting distribution to retailers across Canada. Peak services over 3,500 locations across sports, health, mass retail, e-tail, convenience, grocery, pharmacy, and specialty channels.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Appointment of Patrick W. Sills as Strategic Go-to-Market Advisor. Mr. Sills brings over 15 years of leadership in nicotine and functional CPG sectors with experience at Philip Morris International and Fontem Ventures, providing guidance on product positioning, distribution, regulatory considerations, and market expansion.

7Doseology USA Inc.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wholly owned subsidiary based in Florida for U.S. market entry, established as part of Doseology's strategic expansion into the multi-billion-dollar U.S. modern oral stimulant market.

doseology.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

U.S. tobacco incumbent owning the On! and Helix nicotine pouch brands plus a broader combustible/HP portfolio; competes with Doseology in the same oral pouch format targeting the smoke-free consumer.

TypeDirect peer
Description

Functional mushroom and adaptogenic wellness brand (coffee, elixirs, supplements) selling to the same health-conscious, nootropic-curious consumer Doseology addresses with its Wake/Elevate/Boost/Sleep line.

TypeDirect peer
Description

Paul Stamets-founded medicinal mushroom supplements brand (mycelium-based capsules, extracts) — the most direct peer in Doseology's functional mushroom tincture and Think cognitive complex category.

TypeDirect peer
Description

Smoke-free, tobacco-free, and nicotine-free product maker with hemp-based alternatives sold in similar convenience/specialty retail — closely comparable to Doseology's nicotine-free stimulant pouch thesis.

TypeBroad incumbent
Description

Energy drink company serving health-conscious, fitness-oriented consumers via mass retail — directly comparable customer persona and energy-delivery use case as Doseology's Feed That Brain energy pouches.

TypeEmerging player
Description

Smokeless, tobacco-leaf-free dip alternative brand — directly comparable to Doseology's nicotine-free oral pouch positioning and the broader 'smoke-free oral' thesis.

TypeBroad incumbent
Description

Global tobacco giant whose Zyn brand dominates the modern oral nicotine pouch category — directly relevant to Doseology's oral stimulant pouch platform, with the same buccal delivery format and overlapping retail channels.

8British American Tobacco
TypeBroad incumbent
Description

Owns Velo nicotine pouches and a multi-category smoke-free portfolio; the company is a global category leader in the same oral pouch format Doseology is targeting with Feed That Brain.

9Nordic Spirit (Japan Tobacco International)
TypeBroad incumbent
Description

Japan Tobacco's oral nicotine pouch brand; another global incumbent in the same pouch format Doseology is targeting and a likely long-tail competitive threat in both Canada and the U.S.

10Verve Energy
TypeEmerging player
Description

Emerging energy-pouch / chew brand competing in the same smoke-free, caffeine/nootropic pouch category as Doseology's Feed That Brain — directly comparable format and target consumer.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

doseology

Consumer Health & Wellness Supplementsdoseology.com

Doseology Sciences Inc. is a publicly traded Canadian consumer health company that sells Health Canada-approved functional mushroom supplements through Canadian grocery and health food retail, and caffeine-based oral stimulant pouches under the Feed That Brain brand via a U.S. DTC pilot, targeting health-conscious consumers seeking portable energy and cognitive performance alternatives.

What doseology does

Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) is a publicly traded Canadian consumer products company headquartered in Kelowna, British Columbia, that develops and commercializes functional wellness and oral stimulant products. Its legacy product line is a portfolio of Health Canada NPN-approved medicinal mushroom tinctures and a cognitive complex powder (branded Wake, Elevate, Boost, Sleep, and Think), sold through Canadian grocery and health food retail including Loblaw, Sobeys/Safeway, Whole Foods Market Canada, and Healthy Planet, and distributed nationally by Connect Brand Management and Peak Performance Products, the latter covering over 3,500 retail doors.

The company's current strategic focus is the oral stimulant pouch category, anchored by the Feed That Brain brand acquired from Joseph Mimran & Associates Inc. in August 2025 for CAD 400,000. The core technology is a buccal/oral stimulant pouch delivery platform designed to deliver controlled doses of caffeine, nootropics, and other functional actives without smoke, vapor, sugar, or liquid. Feed That Brain Energy Pouches launched in the U.S. in March 2026 through a direct-to-consumer pilot at feedthatbrain.com and Amazon.com; a Florida-based wholly owned subsidiary, Doseology USA Inc., was established in March 2025 to support U.S. and, over time, European commercialization. The company has engaged McKinney Regulatory Science Advisors to pursue an FDA PMTA pathway for the platform.

The business model is conventional CPG wholesale plus direct-to-consumer e-commerce. Revenue is generated through one-time unit sales to retail channel partners and end consumers, with pricing not publicly disclosed. The go-to-market is multi-channel: enterprise retail partnerships in Canada, national broker/distributor relationships, an affiliate program targeting influencers and digital nomads, trade show presence at CHFA events, and DTC e-commerce. The company has 1-10 employees, is debt-free, and has funded commercialization through a series of non-brokered private placements totaling approximately CAD 6.2M in 2025-2026, with ownership including Maynard Communication Limited (~10.4%) and Jesse McRae (~13.6%) as of June 2025.

doseology firmographics

Firmographics
Name
doseology
Legal name
Doseology Sciences Inc.
Website
https://doseology.com
Company type
Public
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Doseology Sciences Inc. is a publicly traded Canadian consumer health company that sells Health Canada-approved functional mushroom supplements through Canadian grocery and health food retail, and caffeine-based oral stimulant pouches under the Feed That Brain brand via a U.S. DTC pilot, targeting health-conscious consumers seeking portable energy and cognitive performance alternatives.
Ownership category
akta.pro rank

doseology industry classification

Industry
Product category
Consumer Health & Wellness Supplements
NAICS
Medicinal and Botanical Manufacturing (325411), Food (Health) Supplement Retailers (456191)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAGAI
Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots)
SECONDARYCRADAGAD
Herbal & Botanical Supplements
SECONDARYCRADAJAI
Nicotine Pouches (Tobacco-Free) Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands

Keywords

  • Oral stimulant pouches
  • Functional mushroom supplements
  • Caffeine energy pouches
  • Smoke-free nicotine alternatives
  • Nootropic delivery systems

Where doseology is headquartered

Location

Headquarters

HQ city
Kelowna
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

doseology business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Functional Mushroom Product Sales: Sale of functional mushroom tinctures (Wake, Elevate, Boost, Sleep, Think) through retail and direct-to-consumer channels in Canada. Products are Health Canada NPN-approved medicinal mushroom supplements.
  2. Oral Stimulant Pouch Sales: Sale of Feed That Brain Energy Pouches through DTC (feedthatbrain.com, Amazon.com) and eventual retail channels. The nicotine-free, caffeine-based oral stimulant pouches represent the company's next-generation product line.
  3. Wholesale/Distribution Revenue: Wholesale product sales through national retail chains including Loblaw, Sobeys, Whole Foods, and other health food retailers across Canada.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels4 records

doseology product offering

Product offering

Core offering

Doseology Sciences Inc. develops, manufactures, and sells consumer health products focused on oral stimulant pouches and functional mushroom supplements. Its core offerings include the Feed That Brain line of nicotine-free, caffeine-based oral stimulant pouches sold through DTC and retail channels, and Health Canada NPN-approved medicinal mushroom tinctures (Wake, Elevate, Boost, Sleep) plus the Think cognitive complex powder sold through major Canadian grocery and health-food retailers.

Product overview

Doseology Sciences Inc. operates as a consumer product innovation company specializing in oral stimulant and functional wellness products. The company offers two distinct product lines: (1) Feed That Brain Energy Pouches - nicotine-free, caffeine-based oral stimulant pouches for clean, controlled energy delivery; and (2) Functional Mushroom Supplements - Health Canada NPN-approved tinctures (Wake, Elevate, Boost, Sleep) and Think powder featuring 100% mushroom fruiting bodies for cognitive health, mood support, immunity, and sleep. The Feed That Brain brand was acquired in August 2025 and serves as the company's entry into the oral stimulant pouch market, while the mushroom line represents the original product portfolio sold through Canadian retail channels including Loblaw, Sobeys, Whole Foods, and Amazon.

Differentiator

Problem solved

Functional benefit

Brands

  • Feed That Brain: Oral stimulant pouch brand featuring nicotine-free, caffeine-based energy pouches. Launched in U.S. market through direct-to-consumer pilot in March 2026.

Products and services

  • Feed That Brain Energy Pouches Nicotine-free, caffeine-based oral stimulant pouches designed to provide clean, controlled energy in a discreet, portable, and portion-controlled format without sugar, smoke, or liquid consumption. Targeted at health-conscious adult consumers, professionals, and athletes seeking an alternative to traditional energy drinks and tobacco.
  • Doseology Functional Mushroom Tinctures (Wake, Elevate, Boost, Sleep) Health Canada NPN-approved medicinal mushroom tinctures containing 100% mushroom fruiting bodies. Wake promotes wakefulness and cognitive performance; Elevate enhances mood and cognitive clarity; Boost supports immunity; Sleep promotes relaxation and sleep onset. Sold through Canadian grocery, health-food retailers, and e-commerce channels.
  • Think Cognitive Complex Powder Super-shroom cognitive complex powder blending lion's mane, reishi, shiitake, and chaga mushrooms with yerba mate, rhodiola, choline, organic cocoa powder, and monk fruit extract. Formulated to optimize cognitive function and improve focus and alertness.

Quantifiable outcome

  • Year-over-year sales increased by 224%
  • +2 more outcomes

Companies that use doseology

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

doseology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

doseology partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • McKinney Regulatory Science AdvisorscoreStrategic or Co-development Partner · 12 January 2026Strategic partnership with McKinney Regulatory Science Advisors, an FDA regulatory consulting firm, to advance Doseology's regulatory submission strategy for oral pouch technology products. McKinney provides guidance on formulation strategy, PMTA preparation, and post-market compliance to position Doseology for FDA approval and commercial readiness in regulated markets.
  • Guerilla Capital and Maynard Communications Ltd.supportingGTM or Marketing Partner · 1 December 2025Investor Communications Initiative involving collaborations with Guerilla Capital and Maynard Communications Ltd. to improve disclosure practices and investor engagement, supporting long-term strategy for developing oral stimulant platform.
  • Joseph Mimran & Associates Inc.coreStrategic or Co-development Partner · 19 August 2025Acquisition of the Feed That Brain division operated by Joseph Mimran & Associates Inc. for $400,000. Joseph Mimran appointed as strategic advisor under a three-year advisory agreement. The transaction includes all business plan, inventory, contracts, material agreements, intangible property, know-how, and goodwill of the Feed That Brain brand.
  • Connect Brand ManagementcoreChannel Partner/ Reseller/ DistributorNational CPG firm specializing in sales and marketing for leading natural food and nutraceutical brands, engaged to accelerate revenue and product rollout in Canada through extensive relationships throughout the natural product category in grocery, retail, and pharmacy channels.
  • Peak Performance Products Inc.coreChannel Partner/ Reseller/ DistributorLeading distributor of innovative and effective products that optimize health and wellness with a national sales team soliciting distribution to retailers across Canada. Peak services over 3,500 locations across sports, health, mass retail, e-tail, convenience, grocery, pharmacy, and specialty channels.
  • Patrick W. Sills / PWSILCORPsupportingStrategic or Co-development PartnerAppointment of Patrick W. Sills as Strategic Go-to-Market Advisor. Mr. Sills brings over 15 years of leadership in nicotine and functional CPG sectors with experience at Philip Morris International and Fontem Ventures, providing guidance on product positioning, distribution, regulatory considerations, and market expansion.
  • Doseology USA Inc.coreStrategic or Co-development PartnerWholly owned subsidiary based in Florida for U.S. market entry, established as part of Doseology's strategic expansion into the multi-billion-dollar U.S. modern oral stimulant market.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

doseology competitors and assessment

Company assessment

Broad incumbents

  • Altria Group: U.S. tobacco incumbent owning the On! and Helix nicotine pouch brands plus a broader combustible/HP portfolio; competes with Doseology in the same oral pouch format targeting the smoke-free consumer.
  • Celsius Holdings: Energy drink company serving health-conscious, fitness-oriented consumers via mass retail — directly comparable customer persona and energy-delivery use case as Doseology's Feed That Brain energy pouches.
  • Philip Morris International: Global tobacco giant whose Zyn brand dominates the modern oral nicotine pouch category — directly relevant to Doseology's oral stimulant pouch platform, with the same buccal delivery format and overlapping retail channels.
  • British American Tobacco: Owns Velo nicotine pouches and a multi-category smoke-free portfolio; the company is a global category leader in the same oral pouch format Doseology is targeting with Feed That Brain.
  • Nordic Spirit (Japan Tobacco International): Japan Tobacco's oral nicotine pouch brand; another global incumbent in the same pouch format Doseology is targeting and a likely long-tail competitive threat in both Canada and the U.S.

Direct peers

  • Four Sigmatic: Functional mushroom and adaptogenic wellness brand (coffee, elixirs, supplements) selling to the same health-conscious, nootropic-curious consumer Doseology addresses with its Wake/Elevate/Boost/Sleep line.
  • Host Defense Mushrooms: Paul Stamets-founded medicinal mushroom supplements brand (mycelium-based capsules, extracts) — the most direct peer in Doseology's functional mushroom tincture and Think cognitive complex category.
  • TAAT Global Alternatives: Smoke-free, tobacco-free, and nicotine-free product maker with hemp-based alternatives sold in similar convenience/specialty retail — closely comparable to Doseology's nicotine-free stimulant pouch thesis.

Emerging players

  • Black Buffalo: Smokeless, tobacco-leaf-free dip alternative brand — directly comparable to Doseology's nicotine-free oral pouch positioning and the broader 'smoke-free oral' thesis.
  • Verve Energy: Emerging energy-pouch / chew brand competing in the same smoke-free, caffeine/nootropic pouch category as Doseology's Feed That Brain — directly comparable format and target consumer.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

doseology social profiles

Digital presence

doseology compliance and trust

Trust signal

Compliance1 record

doseology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

doseology leadership team

Management profile

Number of profiles

Profiles6 records

doseology subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

doseology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

doseology M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about doseology

What does doseology do?

Doseology Sciences Inc. develops, manufactures, and sells consumer health products focused on oral stimulant pouches and functional mushroom supplements. Its core offerings include the Feed That Brain line of nicotine-free, caffeine-based oral stimulant pouches sold through DTC and retail channels, and Health Canada NPN-approved medicinal mushroom tinctures (Wake, Elevate, Boost, Sleep) plus the Think cognitive complex powder sold through major Canadian grocery and health-food retailers.

Is doseology a public or private company?

doseology is a public company. It is classified as public and is currently operating.

When was doseology founded?

doseology was founded in 2021. It employs 1 to 10 people.

Where is doseology based?

doseology is headquartered in Kelowna, Canada, in the North America region.

How does doseology make money?

Three revenue lines are on record. Functional Mushroom Product Sales are the primary driver. The others are oral Stimulant Pouch Sales and wholesale/Distribution Revenue.

Who are doseology's main competitors?

Broad incumbents on record are Altria Group, Celsius Holdings, Philip Morris International, British American Tobacco and Nordic Spirit (Japan Tobacco International). Direct peers are Four Sigmatic, Host Defense Mushrooms and TAAT Global Alternatives. Emerging players are Black Buffalo and Verve Energy.

Does doseology have an API?

No public API is recorded for doseology.

What industry is doseology in?

doseology's product category is Consumer Health & Wellness Supplements. Its primary akta.pro industry code is CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AktienDoseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial StatementsDoseology Sciences Inc. received a management cease trade order for failing to file its annual audited financial statements for the year ended June 30, 2026, by the October 28, 2026 deadline. The company expects the audit to take two additional weeks and plans to file by November 15, 2026, while issuing bi-weekly default status reports.Stock TitanDoseology gets management cease trade order for late filingDoseology Sciences Inc. received a management cease trade order for failing to file its annual audited financial statements for the year ended June 30, 2026, by the October 28, 2026 deadline. The company expects its auditor to need two additional weeks and anticipates filing by November 15, 2026.The future of tradingDoseology Director Larry Latowsky Resigns, Effective ImmediatelyLarry Latowsky resigned as a director of Doseology, effective immediately, on October 14, 2026. The resignation was announced by Doseology Sciences Inc. via Newsfile, with the company taking sole responsibility for the information.The future of tradingDoseology Announces Resignation of DirectorDoseology Sciences Inc. announced that Larry Latowsky resigned as a director, effective immediately. The company, which develops oral pouch and functional stimulant products, is led by Interim CEO Kareem Baalbaki. No further details on the resignation were provided.NewsfileDoseology Announces Resignation of DirectorDoseology Sciences Inc. announced that Larry Latowsky resigned as a director, effective immediately. The company, a consumer product innovation firm focused on oral pouch and functional stimulant products, is led by Interim CEO Kareem Baalbaki.TradingViewDoseology Sciences Inc. (MOOD) Director Resigns Effective ImmediatelyDoseology Sciences Inc. announced that director Larry Latowsky resigned from the board effective immediately. The resignation is a governance update with no stated strategic or financial impact. Further disclosures on board replacement or reasons would determine if it becomes a larger catalyst.TradingViewDoseology Announces Resignation of DirectorDoseology Sciences Inc. announced that Larry Latowsky resigned as a director, effective immediately. The company, a consumer product innovation firm focused on oral pouch and functional stimulant products, is led by Interim CEO Kareem Baalbaki.AktienDoseology Announces Resignation of DirectorDoseology Sciences Inc. announced that Larry Latowsky resigned as a director, effective immediately. The company, which develops oral pouch and functional stimulant products, did not disclose the reason for the resignation.Third NewsDoseology Unveils New Leadership and Completes Shares-for-Debt SettlementDoseology Sciences appointed Kareem Baalbaki as interim CEO and CFO and Jeremy Wright as CFO, replacing Chris Jackson and Chris Cherry. The company settled $13,548.39 in consulting debt by issuing 75,268 shares at $0.18 each. The leadership shift supports its oral pouch stimulant product growth.